Institute of Good Manufacturing Practices India

Global accredited training & certification provider

IGMPI Approvals & Accreditation : Approved by Quality Council of India (QCI) & Accredited Vocational Institution of Ministry of HRD, Government of India, Approved Training Institute of Food Safety and Standards Authority of India (FSSAI), Recognized by Department of Industrial Policy & Promotion, Ministry of Commerce & Industry, Government of India, An ISO 9001:2015 Certified Organisation registered under The Societies Registration Act,1860 Government of India Empanelled under Ministry of Horticulture and Food Processing, Government of Uttar Pradesh, Affiliated with Life Sciences and Food Industry Sector Skills Council (SSC)
Trusted by organizations & training participants in over 30 countries. Training | Certification | Education | Research

Significant improvements observed for new inhaled treatment by Novartis during phase II data

22nd May 2019

Novartis is developing the new combination for asthma treatment which will be given once daily. It involves the combination of indacaterol acetate /glycopyrronium bromide, which imparts bronchodilation effect along with momentasone furoate through dose controlling Breezhaler.

A favorable tolerable and safety profile is demonstrated by IND/GLY/MF in phase II studies. The combination was observed to improvise the lung functioning in comparison to placebo. Also, time of administration has no effect on its functioning.

This new inhaled combination is found to be superior in comparison to LABA/ICS long-acting beta agonist/inhaled corticosteroid. No severe adverse effects were observed during the treatment period. The phase III clinical trials of IND/GLY/MF are ongoing.

About one-third asthmatic patients are experiencing exacerbations despite the accessibility of several treatments for asthma. Breezhaler is already established to be used in COPD. If the new combination will get the approval, then this would be beneficial for patients who have uncontrolled asthma.

For further enquiries, write to or call us on: +91 8587838177, +91 8130924488, 0120-2427175

Pharmaceuticals | Food | Clinical Research | Healthcare | Medical Coding | Medical Device | Nanotechnology | IPR

Placement testimonials: Our alumni are working with Fortune 500 and global Pharmaceutical, Food and healthcare giants like